Center for Kidney Disease, Second Affiliated Hospital, Nanjing Medical University, Nanjing, PR China.
State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Advanced Institute of Life Sciences, Nanjing, PR China.
J Pathol. 2019 Mar;247(3):392-405. doi: 10.1002/path.5198. Epub 2018 Dec 28.
Acute kidney injury (AKI) is a public health concern, with high morbidity and mortality rates in hospitalized patients and because survivors have an increased risk of progression to chronic kidney disease. Mitochondrial damage is the critical driver of AKI-associated dysfunction and loss of tubular epithelial cells; however, the pathways that mediate these events are poorly defined. Here, in murine ischemia/reperfusion (I/R)-induced AKI, we determined that mitochondrial damage is associated with the level of renal uncoupling protein 2 (UCP2). In hypoxia-damaged proximal tubular cells, a disruption of mitochondrial dynamics demonstrated by mitochondrial fragmentation and disturbance between fusion and fission was clearly indicated. Ucp2-deficient mice (knockout mice) with I/R injury experienced more severe AKI and mitochondrial fragmentation than wild-type mice. Moreover, genetic or pharmacological treatment increased UCP2 expression, improved renal function, reduced tubular injury and limited mitochondrial fission. In cultured proximal tubular epithelial cells, hypoxia-induced mitochondrial fission was exacerbated in cells with UCP2 deletion, whereas an increase in UCP2 ameliorated the hypoxia-induced disturbance of the balance between mitochondrial fusion and fission. Furthermore, results following modulation of UCP2 suggested it has a role in preserving mitochondrial integrity by preventing loss of membrane potential and reducing subsequent mitophagy. Taken together, our results indicate that UCP2 is protective against AKI and suggest that enhancing UCP2 to improve mitochondrial dynamics has potential as a strategy for improving outcomes of renal injury. Copyright © 2018 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
急性肾损伤(AKI)是一个公共卫生关注点,住院患者的发病率和死亡率都很高,而且幸存者进展为慢性肾脏病的风险增加。线粒体损伤是 AKI 相关功能障碍和肾小管上皮细胞丢失的关键驱动因素;然而,介导这些事件的途径还没有被很好地定义。在这里,在鼠缺血/再灌注(I/R)诱导的 AKI 中,我们确定线粒体损伤与肾脏解偶联蛋白 2(UCP2)的水平有关。在缺氧损伤的近端肾小管细胞中,线粒体动力学的破坏通过线粒体碎片化和融合与分裂之间的干扰明显表明。与野生型小鼠相比,Ucp2 缺陷型(敲除型)小鼠(敲除型)的 I/R 损伤导致更严重的 AKI 和线粒体碎片化。此外,遗传或药物治疗增加 UCP2 的表达,改善肾功能,减少肾小管损伤,限制线粒体分裂。在培养的近端肾小管上皮细胞中,UCP2 缺失的细胞中缺氧诱导的线粒体分裂加剧,而 UCP2 的增加则改善了缺氧诱导的线粒体融合和分裂之间平衡的紊乱。此外,对 UCP2 进行调节后的结果表明,它通过防止膜电位丧失和减少随后的线粒体自噬来保护线粒体的完整性。总之,我们的研究结果表明 UCP2 对 AKI 具有保护作用,并表明增强 UCP2 以改善线粒体动力学可能是改善肾损伤结果的一种策略。版权所有©2018 英国和爱尔兰病理学学会。由 John Wiley & Sons,Ltd. 出版。